| 2001 | |
| Stéphane Boissel | |
Chargement de la carte ... |
|
| 50 | |
| 15 | |
| Euronext | |
| TXCL | |
| 66 M€ | |
| 07/2021 | |
| FR0010127662 | |
| 10.8 | |
| www.txcell.com | |
| TxCell develops innovative, personnalized cellular immunotherapies using regulatory T cells for severe chronic inflammatory and autoimmune diseases, with 2 platfroms: ASTrIA (Treg) & ENTrIA (CAR-Treg) |
Fiche créée le 19/07/2021 par T Thiboude vue 4 fois.